Early research (Phase 1)Study completedNCT05765604
What this trial is testing
Phase I Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) (WSK-V102)
Who this might be right for
COVID-19
WestVac Biopharma Co., Ltd. 72
Showing 20 of 0 results